Search results for "Fever"

showing 10 items of 247 documents

Demonstration of spotted fever group rickettsiae in the tache noire of a healthy person in Sicily.

1984

A human case of rickettsial infection occurred in Sicily following tick bite. The patient did not have fever, the typical nodular rash, or other symptoms of illness other than development of a tache noire containing spotted fever group rickettsiae, which were demonstrated by immunofluorescence. A high titer of antibodies of the IgG class suggests that the patient may have had previous exposure to Rickettsia conorii or a related spotted fever group rickettsia. An anamnestic response may be hypothesized to have conferred partial immunity, with resulting containment of rickettsiae at the site of inoculation.

MaleFluorescent Antibody TechniqueRickettsiaceae InfectionsTickBoutonneuse FeverVirologySkin UlcermedicineHumansRickettsiaSicilybiologyTache noir de la sclerotiqueMiddle Agedbacterial infections and mycosesmedicine.diseasebiology.organism_classificationRashVirologyAntibodies BacterialSpotted feverBoutonneuse feverTiterInfectious DiseasesRickettsiaImmunologybacteriaParasitologymedicine.symptomRickettsia conoriiThe American journal of tropical medicine and hygiene
researchProduct

Isolation and characterization of Bartonella quintana from parotid gland of an immunocompetent man.

2009

We describe a case of the isolation of Bartonella quintana from the parotid gland of an apparently healthy man. Pathological examination showed intraparotid granulomatous abscessual lymphadenitis. Diagnosis was made on the basis of high titers of immunoglobulin G (IgG) and IgM antibodies and of culture isolation of a causative agent from parotid aspirate.

MaleMicrobiology (medical)Pathologymedicine.medical_specialtyIgm antibodyAnti-Inflammatory AgentsCase ReportsImmunoglobulin GMicrobiologyB. quintanastomatognathic systemBartonella quintanaLymphadenitismedicineHumansbiologyMiddle Agedbacterial infections and mycosesbiology.organism_classificationmedicine.diseaseIsolation (microbiology)Antibodies BacterialTrench FeverB. quintana; parotid glandTrench feverAnti-Bacterial AgentsParotid glandstomatognathic diseasesmedicine.anatomical_structureImmunoglobulin MImmunoglobulin MImmunoglobulin Gbiology.proteinbacteriaBartonella quintanaSteroidsParotid DiseasesParotid Diseasesparotid gland
researchProduct

Severe Mediterranean spotted fever complicated by acute renal failure and herpetic oesophagitis

2010

Mediterranean spotted fever (MSF) is a tick-borne disease caused by Rickettsia conorii. Recently, complicated cases have been more frequently reported, even in previously healthy patients. We describe a case of severe MSF complicated by acute renal failure and associated with herpetic oesophagitis. Acyclovir therapy resulted in remission of oesophageal symptoms within 48 h.

MaleMicrobiology (medical)Settore MED/07 - Microbiologia E Microbiologia Clinicamedicine.medical_specialtySettore MED/17 - Malattie InfettiveMediterranean spotted fever renal failure herpetic oesophagitisAcyclovirHerpesvirus 1 HumanAntibodies ViralBoutonneuse FeverAntiviral AgentsMicrobiologyGastroenterologyPharmacotherapyInternal medicinemedicineEsophagitisHumansbiologybusiness.industryHerpes SimplexGeneral MedicineAcute Kidney InjuryMiddle Agedmedicine.diseasebiology.organism_classificationSpotted feverSurgeryBoutonneuse feverRickettsia conoriiTreatment OutcomeRickettsiosisViral diseaseRickettsia conoriibusinessEsophagitisKidney diseaseJournal of Medical Microbiology
researchProduct

Clarithromycin Versus Azithromycin in the Treatment of Mediterranean Spotted Fever in Children: A Randomized Controlled Trial

2002

We conducted an open-label randomized controlled trial to compare the efficacy and safety of clarithromycin (15/mg/kg/day in 2 divided doses for 7 days) with those of azithromycin (10 mg/kg/day in 1 dose for 3 days) in the treatment of children with Mediterranean spotted fever. Until now, there has not been a gold-standard therapy for this rickettsial disease in children. Eighty-seven children were randomized to receive 1 of the 2 drugs. The mean time to defervescence (+/- standard deviation) was 46.2+/-36.4 h in the clarithromycin group and 39.3+/-31.3 h in the azithromycin group. These differences were not statistically significant and both drugs were equally well-tolerated. Clarithromyci…

MaleMicrobiology (medical)medicine.medical_specialtyAdolescentErythromycinAzithromycinBoutonneuse FeverAzithromycinDrug Administration Schedulelaw.inventionRandomized controlled triallawClarithromycinClarithromycinInternal medicinemedicineHumansChildAntibacterial agentMediterranean spotted fever Clarithromycin azithromycinbusiness.industryInfantmedicine.diseaseAnti-Bacterial AgentsSurgerySpotted feverBoutonneuse feverRickettsia conoriiTreatment OutcomeInfectious DiseasesRickettsiosisChild PreschoolFemalebusinessmedicine.drugClinical Infectious Diseases
researchProduct

A 6 day course of liposomal amphotericin B in the treatment of infantile visceral leishmaniasis: the Italian experience

2004

Objectives To evaluate in a retrospective analysis the efficacy and safety of a 6 day course of liposomal amphotericin B (L-AmB) in infantile cases of Mediterranean visceral leishmaniasis (VL) diagnosed over a 10 year period in Italy. Patients and methods Patients included were diagnosed as having VL consecutively admitted from December 1992 to December 2001 at four main referral children's hospitals in Italy and treated with six intravenous doses of 3 mg/kg L-AmB given on days 1-5 and 10 (a total dose of 18 mg/kg). Demographic data, nutritional status, underlying diseases, clinical and laboratory findings, and therapy outcome were considered. Results A total of 164 HIV-negative children (m…

MaleMicrobiology (medical)medicine.medical_specialtyAdolescentFeverAntiprotozoal AgentsFluorescent Antibody TechniqueNutritional Statusitaly; leishmania infantum; therapyBone MarrowRecurrenceAmphotericin BInternal medicineAmphotericin BmedicineHumansPharmacology (medical)ChildAdverse effectleishmaniasisRetrospective StudiesPharmacologyDrug Carriersbiologybusiness.industryInfantRetrospective cohort studyLeishmaniasismedicine.diseasebiology.organism_classificationSurgeryRegimenTreatment OutcomeInfectious DiseasesVisceral leishmaniasisItalyEl NiñoChild PreschoolLiposomesLeishmaniasis VisceralFemaleLeishmania infantumbusinessmedicine.drug
researchProduct

Atrial fibrillation in Mediterranean spotted fever

2008

Mediterranean spotted fever (MSF) is a tick-borne acute febrile disease caused by Rickettsia conorii and characterized by fever, maculo-papular rash and a black eschar at the site of the tick bite (‘tache noir’). We describe the case of a 58-year-old man affected by MSF who developed atrial fibrillation. The patient presented himself to the hospital after 7 days of fever, malaise and severe headache. Cardiac auscultation revealed a chaotic heart rhythm and an electrocardiogram confirmed atrial fibrillation with a fast ventricular response. Diagnosis of MSF was made after the appearance of a maculo-papular skin rash, and treatment with oral doxycycline was started. An immunofluorescence anti…

MaleMicrobiology (medical)medicine.medical_specialtyHeart diseaseEscharBoutonneuse FeverMicrobiologyInternal medicineAtrial FibrillationmedicineHumansbiologybusiness.industryAtrial fibrillationGeneral MedicineMiddle Agedmedicine.diseasebiology.organism_classificationRashMediterranean spotted fever Rickettsia conorii atrial fibrillationSpotted feverSurgeryBoutonneuse feverRickettsiosiscardiovascular systemCardiologymedicine.symptombusinessRickettsia conorii
researchProduct

Leishmaniasis, autoimmune rheumatic disease, and anti–tumor necrosis factor therapy, Europe.

2009

We report 2 cases of leishmaniasis in patients with autoimmune rheumatic diseases in Greece. To assess trends in leishmaniasis reporting in this patient population, we searched the literature for similar reports from Europe. Reports increased during 2004–2008, especially for patients treated with anti–tumor necrosis factor agents.

MaleNecrosisgenetic structuresEpidemiologymedicine.medical_treatmentAnti-Inflammatory Agentslcsh:MedicineAnti-TNF0302 clinical medicineRisk FactorsMedicine030212 general & internal medicinerheumatic diseaseLeishmaniasisLeishmaniaimmunosuppressionbiologyDispatchAntibodies MonoclonalRheumatic diseaseImmunosuppressionMiddle Aged3. Good healthEuropeTreatment OutcomeInfectious DiseasesRheumatic feverFemaleTumor necrosis factor alphaImmunotherapymedicine.symptomMicrobiology (medical)medicine.medical_specialtytumor necrosis factor030231 tropical medicineletterparasiteslcsh:Infectious and parasitic diseases03 medical and health sciencesRheumatic DiseasesAnimalsHumansautoimmune diseaseslcsh:RC109-216Letters to the EditorAged030203 arthritis & rheumatologyTumor Necrosis Factor-alphabusiness.industryscreeninglcsh:RLeishmaniasisImmunotherapyLeishmaniabiology.organism_classificationmedicine.diseaseDermatologyInfliximabAnti-Tumor Necrosis Factor TherapyImmunologysense organsbusinessEmerging Infectious Diseases
researchProduct

Scalp eschar and neck lymphadenopathy caused by Rickettsia massiliae

2013

To the Editor: Scalp eschar and neck lymphadenopathy is a common clinical entity that most frequently affects women and children during spring and fall. It is usually caused by Rickettsia slovaca and R. raoultii. Typical clinical signs are a scalp lesion at the tick bite site and regional, often painful, lymphadenopathy. Acute disease can be followed by residual alopecia at the bite site (1,2). Two designations have been proposed for this syndrome: tick-borne lymphadenopathy and Dermacentor-borne necrosis-erythema-lymphadenopathy (both have been associated with R. slovaca); however, the most generic and all-inclusive term is scalp eschar and neck lymphadenopathy. R. massiliae belongs to the…

MalePathologyLetterEpidemiologylcsh:MedicineSerologyMedicineRickettsiaRickettsia massiliaebacteriafeverbiologyRickettsia InfectiontickInfectious Diseasesmedicine.anatomical_structuremedicine.symptomDermacentorHumanDNA BacterialMicrobiology (medical)medicine.medical_specialtyAdolescentSettore MED/17 - Malattie InfettiveMolecular Sequence DataInfectious DiseaseEscharTicklcsh:Infectious and parasitic diseasesCicatrixBacterial Typing Techniquelymphadenopathylcsh:RC109-216Rickettsia; Rickettsia massiliae; bacteria; eschar; fever; lymphadenopathy; scalp eschar and neck lymphadenopathy; tick; Adolescent; Alopecia; Animals; Bacterial Typing Techniques; Base Sequence; Cicatrix; DNA Bacterial; Dermacentor; Humans; Lymphatic Diseases; Male; Molecular Sequence Data; Rickettsia; Rickettsia Infections; Scalp; Microbiology (medical); Infectious Diseases; EpidemiologyLetters to the EditorDermacentorRickettsia massiliaeScalpScalp EscharBase Sequencebusiness.industryAnimallcsh:RRickettsia massiliae; Scalp Eschar; LymphadenopathyAlopeciascalp eschar and neck lymphadenopathybiology.organism_classificationSpotted feverRickettsiaScalpLymphatic Diseasebusinesseschar
researchProduct

Infant developmental profile of Crisponi syndrome due to compound heterozygosity for CRLF1 deletion.

2020

Crisponi syndrome/CISS1, is an autosomal recessive ciliary neurotrophic factor receptor (CNTFR)-related genodermatosis caused in 95% of cases by mutations in CRLF1 on chromosome 19p13. The CNTFR pathway is important for CNS development. Crisponi syndrome/ CISS1 can be suspected in the presence of the following clinical triad: camptodactyly with fisted hands, intermittent hyperthermia and muscular contractions with feeding difficulties.

MalePathologymedicine.medical_specialtyCrisponi syndromeCompound heterozygosityPathology and Forensic MedicineCamptodactylyDeath SuddenPeriodic feverMedicineHumansHyperhidrosisReceptors CytokineGenetics (clinical)Sequence DeletionDevelopmental profiledevelopmental delay thin corpus callosum clinical profilebusiness.industryInfant NewbornFaciesInfantCold-induced sweating syndromeGeneral MedicineThin corpus callosumPediatrics Perinatology and Child HealthTrismusAnatomymedicine.symptomDevelopmental DelayCold-induced sweating syndrome CamptodactylyThin corpus callosum Periodic feverbusinessHand Deformities CongenitalClinical dysmorphology
researchProduct

Hemorragic presentation of Listeria Monocytogenes rhombencephalic abscess.

2020

Listeria monocytogenes (LM) bacterium is a cause of central nervous system (CNS) infection and the most common cause of rhombencephalitis in immunocompetent elderly. A prompt identification of this condition should be always desirable, since its clinical manifestations are often unspecific with prodromal symptoms leading to high rates of morbidity and mortality if underestimated. CNS listeriosis magnetic resonance imaging (MRI) findings are generally not specific. However, in the appropriate clinical setting, focal brainstem hyperintensity on T2-weighted pulse sequences associated with ring-enhancement pattern after i.v. contrast media injection should be suspicious of LM abscess. The diagn…

MalePathologymedicine.medical_specialtyFeverCentral nervous systemData correlationBrain AbscessHemorrhagemedicine.disease_cause030218 nuclear medicine & medical imagingDiagnosis Differential03 medical and health sciences0302 clinical medicineListeria monocytogenesMedicineHumansBrain magnetic resonance imagingListeriosisAbscessListeria monocytogeneBrain magnetic resonance imagingAgedHigh rateInfectious diseasemedicine.diagnostic_testbusiness.industryHeadacheMagnetic resonance imagingmedicine.diseaseListeria monocytogenesMagnetic Resonance ImagingHyperintensityRhombencephalonmedicine.anatomical_structurebusiness030217 neurology & neurosurgeryMRIJournal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique
researchProduct